BioMendics is led by an experienced, innovative team with a strong track record of success in drug development and clinical trial design and execution. It is guided by a seasoned board of directors with a proven track record of success in drug development, healthcare delivery, finance, and business.
Robert HurwitzChairman of the Board of Directors
Karen M. McGuire, PhDCEO, Founder
Mike Kessel, MBABoard Member
Lauren Rich Fine, MBABoard Member
Jack L. Summers, MD, PhDBoard Member, Co-Founder